Definitive Contract N6264522C0005
Award Date 9/30/22
Potential Completion Date 9/29/25
Potential Value $1.1M
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46250, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the purchase of a LightCycler instrument by the Department of the Navy Bureau of Medicine and Surgery. The contract was awarded to the prime contractor, Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The contract is a firm fixed price purchase order with a potential value of $248,190.00 and a completion date of October 17, 2020. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostics,...
- The U.S. Department of the Navy, Bureau of Medicine and Surgery, awarded a $149,552.00 firm fixed price purchase order contract to Roche Diagnostics Corporation for LIGHTCYCLER URACIL. This award does not have a set-aside designation. Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment, has received multiple federal contract awards to provide critical care analyzers, reagents, test kits, and associated products and...
- This is a $149,578.00 firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a Defense agency, to Roche Diagnostics Corporation for the procurement of LIGHTCYCLER URACIL-DNA equipment and supplies. The contract has an ultimate completion date of August 28, 2015 and was awarded on August 7, 2015, without a set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and...
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer, to provide LightCycler Uracil-DNA Glycosylase products. The $147,918.00 contract has a completion date of October 15, 2019 and did not utilize a set-aside designation. Roche Diagnostics, also known as Roche Diagnostics Corp, has held multiple federal contracts to supply medical equipment, reagents, and testing services...
- Roche Diagnostics Corporation was awarded a firm fixed-price purchase order valued at $5.5K on June 9, 2015, for LightCycler 48-96 coverage (Serial #26230) through a civilian federal agency's Midwest Area office. The contract period runs from July 22, 2015, through July 22, 2016, with performance to be completed in Castleton, Indiana. This award was made without set-aside designations, demonstrating open competition in the federal marketplace. The LightCycler system represents Roche's...
- Roche Diagnostics Corporation was awarded a $18,000 firm fixed-price purchase order by the Southeast Area civilian federal agency on June 17, 2015, for a Light Cycler PCR (polymerase chain reaction) system. The contract, with an ultimate completion date of September 15, 2015, represents a direct acquisition with no set-aside designation. Performance of the work is scheduled to occur in Castleton, Indiana. This purchase order falls within Roche Diagnostics' broader portfolio of federal diagnostic...
- The Department of the Navy Bureau of Medicine and Surgery awarded a $130,670.00 firm fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the supply of LightCycler Uracil-DNA Glycosylase and dNTP Blend kits. This order was awarded without a set-aside designation, as a sole-source award under Federal Acquisition Regulation (FAR) Part 12, Commercial Items. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics,...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for LIGHTCYCLER products. The $47,000.00 firm fixed price delivery order was awarded by the Pacific West Area, a civilian agency within the U.S. government, under the Multiple Award Schedule (MAS) contract vehicle. The award does not utilize a set-aside designation. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and...
- This contract award to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, is for the delivery of LIGHTCYLER URACIL-DNA glycosylase and DNTP BLEND products to the Department of the Navy Bureau of Medicine and Surgery. The $248,190.00 firm fixed price purchase order was awarded on July 20, 2021 with a completion date of August 6, 2021. No set-aside was used for this award. Roche Diagnostics is an established federal contractor, holding multiple General Services...
- This purchase order awarded Roche Diagnostics Corporation a firm fixed-price contract valued at $18,000 for one Roche LightCycler 96 Real Time PCR System (Catalog #5815916001), a molecular diagnostic instrument used for real-time polymerase chain reaction (PCR) testing. The contract, issued on April 29, 2015, with an ultimate completion date of May 8, 2015, was funded by a civilian federal agency's Southeast Area office and performed at a location in Castleton, Indiana. No small business...
The Department of the Navy Bureau of Medicine and Surgery (DoD - Navy) awarded Roche Diagnostics Corporation a $1.13 million definitive contract to provide LightCycler products and services. The firm fixed price contract runs from September 30, 2022 through September 29, 2025 and will be performed in Castleton, Indiana. LightCycler is a real-time PCR system used for genetic and infectious disease testing. Roche Diagnostics Corporation will serve as the prime contractor to provide these laboratory diagnostic technologies to the Navy Bureau of Medicine and Surgery through September 2025.
Generated 11/28/23, 6:38 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1m | 9/27/22 |